John B. Landis - Director at EyePoint Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John B. Landis since 11/21/2023

Holdings reported by John B. Landis for EyePoint Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 10K $204K $20.40 Jan 5, 2024 Direct Common Stock
Stock Option (Right to Buy) 25K Jan 5, 2024 Direct Common Stock

Transactions reported by John B. Landis for EyePoint Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.